Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries by Hyosun Kim :: SSRN

I would like to take this opportunity to express my deepest gratitude to everyone who responded to my study entitled: “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.” Scholars from several different fields, including medical science, pharmacy, business, and communication have all participated in the discussion of current issues and the future of direct-to consumer advertising (DTCA), bringing multifaceted viewpoints to bear on prescription drug marketing based on their own disciplines.

Source: Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries by Hyosun Kim :: SSRN

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s